Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SK-0403 Dose Finding Study in T2D Patients on Metformin
NCT01169090Phase 2Completed
- Start
- Jul 2010
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anagliptin in type 2 diabetes mellitus (T2DM). Started Jul 2010; status: completed.
02
Drugs
anagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01169090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01169090.